TY - JOUR AU - Casadevall, N. AU - Nataf, J. AU - Viron, B. AU - Kolta, A. AU - Kiladjian, J. J. AU - Martin-Dupont, P. AU - Michaud, P. AU - Papo, T. AU - Ugo, V. AU - Teyssandier, I. PY - 2002 DA - 2002// TI - Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011931 DO - 10.1056/NEJMoa011931 ID - Casadevall2002 ER - TY - JOUR AU - Nigg, L. AU - Schanz, U. AU - Ambuhl, P. M. AU - Fehr, J. AU - Bachli, E. B. PY - 2004 DA - 2004// TI - Prolonged course of pure red cell aplasia after erythropoietin therapy JO - Eur J Haematol VL - 73 UR - https://doi.org/10.1111/j.1600-0609.2004.00317.x DO - 10.1111/j.1600-0609.2004.00317.x ID - Nigg2004 ER - TY - JOUR AU - Asari, A. AU - Gokal, R. PY - 2004 DA - 2004// TI - Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis JO - J Am Society Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000135056.81056.A4 DO - 10.1097/01.ASN.0000135056.81056.A4 ID - Asari2004 ER - TY - JOUR AU - McKoy, J. M. AU - Stonecash, R. E. AU - Cournoyer, D. AU - Rossert, J. AU - Nissenson, A. R. AU - Raisch, D. W. AU - Casadevall, N. AU - Bennett, C. L. PY - 2008 DA - 2008// TI - Epoetin-associated pure red cell aplasia: past, present, and future considerations JO - Transfusion VL - 48 UR - https://doi.org/10.1111/j.1537-2995.2008.01749.x DO - 10.1111/j.1537-2995.2008.01749.x ID - McKoy2008 ER - TY - JOUR AU - Casadevall, N. PY - 2003 DA - 2003// TI - Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin JO - Nephrol Dialysis Transplantation VL - 18 ID - Casadevall2003 ER - TY - JOUR AU - Casadevall, N. AU - Eckardt, K. U. AU - Rossert, J. PY - 2005 DA - 2005// TI - Epoetin-induced autoimmune pure red cell aplasia JO - J Am Society Nephrol VL - 16 UR - https://doi.org/10.1681/ASN.2004110959 DO - 10.1681/ASN.2004110959 ID - Casadevall2005 ER - TY - JOUR AU - Shinohara, K. AU - Mitani, N. AU - Miyazaki, M. AU - Sakuragi, S. AU - Matsuda, K. AU - Ogawara, S. AU - Saito, T. AU - Kaneoka, H. AU - Ooji, T. PY - 2005 DA - 2005// TI - Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure JO - Am J Hematol VL - 78 UR - https://doi.org/10.1002/ajh.20245 DO - 10.1002/ajh.20245 ID - Shinohara2005 ER - TY - JOUR AU - Katagiri, D. AU - Shibata, M. AU - Katsuki, T. AU - Masumoto, S. AU - Katsuma, A. AU - Minami, E. AU - Hoshino, T. AU - Inoue, T. AU - Tada, M. AU - Hinoshita, F. PY - 2010 DA - 2010// TI - Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone JO - Clin Exp Nephrol VL - 14 UR - https://doi.org/10.1007/s10157-010-0318-8 DO - 10.1007/s10157-010-0318-8 ID - Katagiri2010 ER - TY - JOUR AU - Aoki, K. AU - Ono, Y. AU - Tabata, S. AU - Matsushita, A. AU - Ishikawa, T. PY - 2013 DA - 2013// TI - Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone JO - Int J Hematol VL - 97 UR - https://doi.org/10.1007/s12185-013-1258-3 DO - 10.1007/s12185-013-1258-3 ID - Aoki2013 ER - TY - JOUR AU - Hashimoto, K. AU - Harada, M. AU - Kamijo, Y. PY - 2016 DA - 2016// TI - Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus JO - Int J Hematol VL - 104 UR - https://doi.org/10.1007/s12185-016-2047-6 DO - 10.1007/s12185-016-2047-6 ID - Hashimoto2016 ER - TY - JOUR AU - Boven, K. AU - Stryker, S. AU - Knight, J. AU - Thomas, A. AU - Regenmortel, M. AU - Kemeny, D. M. AU - Power, D. AU - Rossert, J. AU - Casadevall, N. PY - 2005 DA - 2005// TI - The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes JO - Kidney Int VL - 67 UR - https://doi.org/10.1111/j.1523-1755.2005.00340.x DO - 10.1111/j.1523-1755.2005.00340.x ID - Boven2005 ER - TY - JOUR AU - Jenke, D. PY - 2003 DA - 2003// TI - Extractable/leachable substances from plastic materials used as pharmaceutical product containers/devices JO - PDA J Pharm Sci Technol VL - 57 ID - Jenke2003 ER - TY - JOUR AU - Eckardt, K. U. AU - Casadevall, N. PY - 2003 DA - 2003// TI - Pure red-cell aplasia due to anti-erythropoietin antibodies JO - Nephrol Dialysis Transplantation VL - 18 UR - https://doi.org/10.1093/ndt/gfg182 DO - 10.1093/ndt/gfg182 ID - Eckardt2003 ER - TY - JOUR AU - Macdougall, I. C. PY - 2005 DA - 2005// TI - CERA (continuous erythropoietin receptor activator): a new erythropoiesis-stimulating agent for the treatment of anemia JO - Current Hematol Reports VL - 4 ID - Macdougall2005 ER - TY - JOUR AU - Macdougall, I. C. AU - Robson, R. AU - Opatrna, S. AU - Liogier, X. AU - Pannier, A. AU - Jordan, P. AU - Dougherty, F. C. AU - Reigner, B. PY - 2006 DA - 2006// TI - Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.a.) in patients with chronic kidney disease JO - Clin J Am Soc Nephrol VL - 1 UR - https://doi.org/10.2215/CJN.00730306 DO - 10.2215/CJN.00730306 ID - Macdougall2006 ER - TY - JOUR AU - Fuertges, F. AU - Abuchowski, A. PY - 1990 DA - 1990// TI - The clinical efficacy of poly (ethylene glycol)-modified proteins JO - J Control Release VL - 11 UR - https://doi.org/10.1016/0168-3659(90)90127-F DO - 10.1016/0168-3659(90)90127-F ID - Fuertges1990 ER - TY - JOUR AU - Thorpe, R. AU - Swanson, S. J. PY - 2005 DA - 2005// TI - Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures JO - Nephrol Dialysis Transplantation VL - 20 UR - https://doi.org/10.1093/ndt/gfh1086 DO - 10.1093/ndt/gfh1086 ID - Thorpe2005 ER - TY - JOUR AU - Pollock, C. AU - Johnson, D. W. AU - Horl, W. H. AU - Rossert, J. AU - Casadevall, N. AU - Schellekens, H. AU - Delage, R. AU - Francisco, A. AU - Macdougall, I. AU - Thorpe, R. PY - 2008 DA - 2008// TI - Pure red cell aplasia induced by erythropoiesis-stimulating agents JO - Clin J Am Society Nephrol VL - 3 UR - https://doi.org/10.2215/CJN.02440607 DO - 10.2215/CJN.02440607 ID - Pollock2008 ER - TY - JOUR AU - Rossert, J. AU - Macdougall, I. AU - Casadevall, N. PY - 2005 DA - 2005// TI - Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options JO - Nephrol Dialysis Transplantation VL - 20 UR - https://doi.org/10.1093/ndt/gfh1090 DO - 10.1093/ndt/gfh1090 ID - Rossert2005 ER - TY - JOUR AU - Verhelst, D. AU - Rossert, J. AU - Casadevall, N. AU - Kruger, A. AU - Eckardt, K. U. AU - Macdougall, I. C. PY - 2004 DA - 2004// TI - Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)16302-2 DO - 10.1016/S0140-6736(04)16302-2 ID - Verhelst2004 ER - TY - JOUR AU - Snanoudj, R. AU - Beaudreuil, S. AU - Arzouk, N. AU - Jacq, D. AU - Casadevall, N. AU - Charpentier, B. AU - Durrbach, A. PY - 2003 DA - 2003// TI - Recovery from pure red cell aplasia caused by anti-erythropoietin antibodies after kidney transplantation JO - Am J Transplant VL - 4 UR - https://doi.org/10.1046/j.1600-6143.2003.00297.x DO - 10.1046/j.1600-6143.2003.00297.x ID - Snanoudj2003 ER - TY - JOUR AU - Fraer, M. AU - Campbell, A. AU - Sawaya, B. P. PY - 2006 DA - 2006// TI - Response to cyclosporine a in a patient with pure red cell aplasia due to antierythropoietin-alpha antibodies JO - Semin Dial VL - 19 UR - https://doi.org/10.1111/j.1525-139X.2006.00163.x DO - 10.1111/j.1525-139X.2006.00163.x ID - Fraer2006 ER - TY - JOUR AU - Mandreoli, M. AU - Finelli, C. AU - Lopez, A. AU - Ascani, S. AU - Vianelli, N. AU - Baccarani, M. AU - Santoro, A. PY - 2004 DA - 2004// TI - Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia JO - Am J Kidney Diseases VL - 44 UR - https://doi.org/10.1016/S0272-6386(04)00948-5 DO - 10.1016/S0272-6386(04)00948-5 ID - Mandreoli2004 ER - TY - JOUR AU - Westerlund, P. AU - Kurkus, J. AU - Segelmark, M. PY - 2005 DA - 2005// TI - Rapid resolution of EPO-induced pure red cell aplasia after a course of immunoadsorption therapy using protein a columns JO - Am J Kidney Dis VL - 45 UR - https://doi.org/10.1053/j.ajkd.2005.03.011 DO - 10.1053/j.ajkd.2005.03.011 ID - Westerlund2005 ER - TY - JOUR AU - Sawada, K. AU - Hirokawa, M. AU - Fujishima, N. AU - Teramura, M. AU - Bessho, M. AU - Dan, K. AU - Tsurumi, H. AU - Nakao, S. AU - Urabe, A. AU - Omine, M. PY - 2007 DA - 2007// TI - Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine a. a nationwide cohort study in Japan for the PRCA collaborative study group JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.11192 DO - 10.3324/haematol.11192 ID - Sawada2007 ER - TY - JOUR AU - Porter, S. PY - 2001 DA - 2001// TI - Human immune response to recombinant human proteins JO - J Pharm Sci VL - 90 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Porter2001 ER -